CN Stock MarketDetailed Quotes

688289 Sansure Biotech Inc.

Watchlist
  • 22.01
  • -0.69-3.04%
Noon Break Jan 2 11:29 CST
12.82BMarket Cap49.46P/E (TTM)

Sansure Biotech Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sansure Biotech Inc. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.988B--
--2024/FY-- / 1.491B--
--2023/FY1.006B / ----
--2021/FY4.515B / 4.321B--
--2020/FY4.767B / 5.080B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.988B--
--2024/FY-- / 1.491B--
--2023/FY1.006B / ----
--2021/FY4.515B / 4.321B--
--2020/FY4.767B / 5.080B--

Unlock Free Earnings Estimates

Sansure Biotech Inc. Earnings Reports

  • Shengxiang Biology: Shengxiang Biotechnology Co., Ltd. Report for the Third Quarter of 2024

    Oct 23, 2024 12:00 ET

  • Shengxiang Biotechnology Co., Ltd. Report for the Third Quarter of 2024

    Oct 23, 2024 12:00 ET

  • Full text of Sansure Biotech Inc.'s 2024 interim report

    Aug 18, 2024 12:00 ET

  • Summary of Sansure Biotech Inc.'s 2024 half-yearly report.

    Aug 18, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 1, 2025

    Strong Buy

    • Strong Buy

      84.62%

    • Buy

      15.39%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Gene Sequencing
    Gene Sequencing
    Intraday+0.03%
    Biomedical
    Biomedical
    Intraday-0.23%
    Specialized, Special and New
    Specialized, Special and New
    Intraday-0.57%